Yu Li

Core-shell nanofiber-mediated delivery of fucoxanthin enhances its bioavailability and alleviates non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) remains a major health challenge, and although fucoxanthin (Fx) shows therapeutic potential, its poor stability and low bioavailability limit clinical application. In this study, a novel delivery system for Fx, a marine-derived xanthophyll carotenoid with anti-obesity, anti...